Investing.com - Takeda Pharma ADR reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Takeda Pharma ADR announced earnings per share of $0.01 on revenue of $7.56B. Analysts polled by Investing.com anticipated EPS of $0.15 on revenue of $7.81B.
Takeda Pharma ADR shares are down 18.4% from the beginning of the year, still down 23.08% from its 52 week high of $20.93 set on November 19, 2019. They are under-performing the EUR/USD which is down 0% from the start of the year.
Takeda Pharma ADR follows other major sector earnings this month
Takeda Pharma ADR's report follows an earnings missed by HSBC Holdings PLC ADR on Tuesday, who reported EPS of $0.21 on revenue of $12.07B, compared to forecasts EPS of $0.24 on revenue of $12.09B.
Iberdrola SA had missed expectations on October 21 with third quarter EPS of $0.59 on revenue of $9.24B, compared to forecast for EPS of $0.66 on revenue of $7.74B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar